Tenax Therapeutics Investor Relations Material
Latest events
Corporate Presentation
26 Jun, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tenax Therapeutics Inc
Access all reports
Tenax Therapeutics Inc is a U.S.-based pharmaceutical company engaged in the development of therapies for cardiovascular and pulmonary diseases. The company focuses on late-stage clinical development and regulatory advancement of drug candidates aimed at addressing unmet medical needs in rare conditions. It operates within the biotechnology sector and collaborates with research institutions and clinical networks. The company is headquartered in Chapel Hill, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Tenax Therapeutics Inc
Corporate Presentation
Tenax Therapeutics Inc
Corporate Presentation
Tenax Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TENX
Country
🇺🇸 United States